Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Interventional Radiology

Smart Speaker Technology Harnessed for Hospital Medical Treatments

April 10, 2019 —Smart speakers customarily used in your living room can act as an aid to physicians in hospital ...

April 10, 2019

News | Guidewires

Straight Tip Guidewires Will Continue to Lead Global Guidewire Market Demand

April 10, 2019 — According to a new research study, straight tip guidewires, with a current share of more than a third ...

April 10, 2019

News | Heart Valve Technology | Jeff Zagoudis, Associate Editor

Mick Jagger Recovering After TAVR Procedure

April 8, 2019 — Rolling Stones frontman Mick Jagger is reportedly recovering after undergoing a transcatheter aortic ...

April 08, 2019

The ScImage cloud-based PICOM365 enterprise cardiology is one of the newer generation echo reporting solutions that offers several ways to streamline workflow.

Feature | Cardiovascular Ultrasound | Dave Fornell, Editor

What to Look for In Echo Reporting Software Systems

Echocardiography reporting systems are usually integrated with, or offered as an add-on module for a cardiovascular ...

April 08, 2019

News | Defibrillator Monitors

HeartHero Personal Automated External Defibrillator Wins ACC.19 Innovation Challenge

April 5, 2019 — Medical device startup HeartHero was the winner in the Innovation Challenge at the 2019 American College ...

April 05, 2019

News | Ventricular Assist Devices (VAD)

Cardiogenic Shock Survival Rates Improve in Three Years Since Impella FDA Approval

April 5, 2019 — Three years ago this week, Abiomed's Impella heart pump received U.S. Food and Drug Administration (FDA) ...

April 05, 2019

Evolut Low Risk Trial compared the minimally invasive Evolut transcatheter aortic valve replacement (TAVR) system to the gold standard of open-heart surgery in characteristically younger, healthier aortic stenosis patients. The randomized trial, which met its primary non-inferiority endpoint of all-cause mortality or disabling stroke at two years compared to surgery (5.3 vs. 6.7 percent; posterior probability of non-inferiority >0.999), was presented at the American College of Cardiology (ACC) 2019 meeting

News | Heart Valve Technology

TAVR Performs Well Compared to Surgical Aortic Valve Replacement in Low Risk Patients

April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut ...

April 03, 2019

The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral Vascular's Covera Vascular Covered Stent for the treatment of a stenosis or blockage which has developed anywhere in the access circuit of patients on hemodialysis using an arteriovenous (AV) fistula.

Technology | Stents

New Indication Added for Covered Stent to Treat Hemodialysis AV Fistula

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral ...

April 03, 2019

The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous Stent System intended to treat narrowed iliofemoral veins.

Technology | Venous Therapies

FDA Clears Venous Stent for the Iliofemoral Veins

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous ...

April 03, 2019

Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore Manta Vascular Closure Device. It is designed to close large puncture sites in the femoral artery from larger sized transcatheter devices, including the Impella heart pump, endovascular stent grafts and transcatheter valves.

Technology | Vascular Closure Devices

Large-Bore Vascular Closure Device Cleared by the FDA

April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore ...

April 03, 2019

News | Resuscitation Devices

Compression-Only CPR Increases Out-of-Hospital Cardiac Arrest Survival

April 2, 2019 — A Swedish review of out-of-hospital cardiac arrest data shows rates of bystander cardiopulmonary ...

April 02, 2019

The top cardiac technology news item in March was the FDA clearing the MitraClip for use in heart failure patients with functional mitral regurgitation based on the very positive results of the COAPT Trial.

Feature

April 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) maga ...

April 01, 2019

News | Heart Failure

Diabetes Drug Effective Against Heart Failure in Wide Spectrum of Patients

March 29, 2019 — The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of ...

March 29, 2019

All major vendors offering advanced visualization software now offer structural heart planning. This is an example of GE Healthcare's Valve Assist software being used to determine the best location of a transseptal puncture to deliver a left atrial appendage (LAA) occluder.

Feature | Structural Heart | Jeff Zagoudis

The Essentials of Structural Heart Imaging

Structural heart interventions represent one of the fastest growing segments of cardiology, as the number of devices to ...

March 28, 2019

Videos

VIDEO: The Role of the NCDR in Boosting Cardiology Quality Improvement

Interview with Frederick Masoudi, M.D., FACC, FAHA, professor of cardiology at the University of Colorado Hospital, and ...

March 28, 2019